» Articles » PMID: 29852199

Selenium Unmasks Protective Iron Armor: A Possible Defense Against Cutaneous Inflammation and Cancer

Overview
Publisher Elsevier
Specialties Biochemistry
Biophysics
Date 2018 Jun 1
PMID 29852199
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A link between selenium deficiency and inflammatory skin diseases have been noted by many, but this link is still not well understood. We have previously studied the efficacy of ceramide analogs, based on the fire ant venom Solenopsin A, against our psoriasis animal model. Treatment of animals with solenopsin analogs resulted in significantly improved skin as well as in a coordinate downregulation of selenoproteins, namely Glutathione Peroxidase 4 (GPX4). We thus hypothesize that ferroptosis may be a physiologic process that may protect the skin from both inflammatory and neoplastic processes.

Methods: We analyze and compare gene expression profiles in the GEO database from clinical skin samples taken from healthy patients and psoriasis patients (both involved and noninvolved skin lesions). We validated the gene expression results against a second, independent, cohort from the GEO database.

Results: Significant reduction in gene expression of GPX4, elevated expression of Nrf2 downstream targets, and expression profiles mirroring erastin-inhibition of Cystine/Glutamate Antiporter-System X activity in psoriatic skin lesions, compared to both noninvolved skin and healthy patient samples, suggest an innately inducible mechanism of ferroptosis.

Conclusions: We present data that may indicate selenoproteins, particularly GPX4, in resolving inflammation and skin cancer, including the novel hypothesis that the human organism may downregulate GPX4 and reactive oxygen (REDOX) regulating proteins in the skin as a way of resolving psoriasis and nonmelanoma skin cancer through increased reactive oxygen species. Further studies are needed to investigate ferroptosis as a possible physiologic mechanism for eliminating inflammatory and malignant tissues.

General Significance: This study provides a fresh framework for understanding the seemingly contradictory effects of selenium supplementation. In addition, it offers a novel explanation of how physiologic upregulation of ferroptosis and downregulation of selenoprotein synthesis may mediate resolution of inflammation and carcinogenesis. This is of therapeutic significance.

Citing Articles

Vascular endothelial growth factor A inhibition remodels the transcriptional signature of lipid metabolism in psoriasis non-lesional skin in 12 h ex vivo culture.

Luengas-Martinez A, Ismail D, Paus R, Young H Skin Health Dis. 2024; 4(6):e471.

PMID: 39624732 PMC: 11608907. DOI: 10.1002/ski2.471.


Ferroptosis of select skin epithelial cells initiates and maintains chronic systemic immune-mediated psoriatic disease.

Vats K, Tian H, Singh K, Tyurina Y, Sparvero L, Tyurin V J Clin Invest. 2024; 135(2.

PMID: 39570671 PMC: 11735110. DOI: 10.1172/JCI183219.


Repair and regeneration: ferroptosis in the process of remodeling and fibrosis in impaired organs.

Yin J, Xu X, Guo Y, Sun C, Yang Y, Liu H Cell Death Discov. 2024; 10(1):424.

PMID: 39358326 PMC: 11447141. DOI: 10.1038/s41420-024-02181-2.


Pilot study of the role of ferroptosis in abnormal biological behaviour of keratinocytes in psoriasis vulgaris.

Wu N, Hu Q, Fu Z, Tong X, Gao L, Tan L Arch Dermatol Res. 2024; 316(8):604.

PMID: 39240413 DOI: 10.1007/s00403-024-03345-x.


Saikosaponin A attenuates osteoclastogenesis and bone loss by inducing ferroptosis.

Li T, Liu Y, Feng C, Bai J, Wang Z, Zhang X Front Mol Biosci. 2024; 11:1390257.

PMID: 39114369 PMC: 11303733. DOI: 10.3389/fmolb.2024.1390257.


References
1.
Shin C, Mishra P, Watrous J, Carelli V, DAurelio M, Jain M . The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Nat Commun. 2017; 8:15074. PMC: 5413954. DOI: 10.1038/ncomms15074. View

2.
Shimauchi T, Hirakawa S, Suzuki T, Yasuma A, Majima Y, Tatsuno K . Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis. J Dermatol. 2013; 40(10):805-12. DOI: 10.1111/1346-8138.12248. View

3.
Yamaguchi H, Kitayama J, Takuwa N, Arikawa K, Inoki I, Takehara K . Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem J. 2003; 374(Pt 3):715-22. PMC: 1223636. DOI: 10.1042/BJ20030381. View

4.
Llambi F, Wang Y, Victor B, Yang M, Schneider D, Gingras S . BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation. Cell. 2016; 165(2):421-33. PMC: 5018360. DOI: 10.1016/j.cell.2016.02.026. View

5.
Wu Y, Chen J, Li Y, Ma G, Chen J, Gao X . Treatment of psoriasis with interleukin-12/23 monoclonal antibody: a systematic review. Eur J Dermatol. 2012; 22(1):72-82. DOI: 10.1684/ejd.2011.1559. View